{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:09:26Z","timestamp":1771474166488,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["JP22K08540"],"award-info":[{"award-number":["JP22K08540"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We evaluated the association between anti-ribosomal P antibody (anti-RibP) titres and disease activity in Japanese SLE patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Eighty patients admitted and treated in Niigata University Hospital for new-onset or flare-up of SLE were included in this retrospective cross-sectional study. Clinical data were obtained from medical records at admission. The anti-RibP index, and cytokine and tryptophan metabolite levels were determined by ELISA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 80 SLE patients, 30 had anti-RibP. Anti-RibP presence was associated with a greater prevalence of skin rash and more severe inflammatory responses, demonstrated by higher inflammatory cytokine levels, hypocomplementemia, and accelerated tryptophan metabolism, in younger patients. The serum anti-RibP index was correlated with age at diagnosis, clinical indicators, initial prednisolone dose, and cytokines and tryptophan metabolite levels in univariate analysis. Multivariate analysis showed that the anti-RibP index was independently associated with the initial prednisolone dose and the prevalence of skin rash. The anti-RibP IgGs were mainly the IgG2 and IgG3 subclasses, and anti-RibP IgG3 was associated with hypocomplementemia, higher DAS, accelerated kynurenine pathway activity, and higher proinflammatory cytokine production. The coexistence of anti-dsDNA IgG and anti-RibP IgG2 or IgG3 accompanied higher IL-10 and IFN-\u03b12 levels; furthermore, anti-RibP IgG3 coexistence with anti-dsDNA antibody contributed to the requirement for higher initial prednisolone doses and accelerated kynurenine pathway activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Anti-RibP was associated with clinical manifestations and parameters in SLE, and its index might be a useful indicator of disease severity. Anti-RibP IgG3 was the IgG subclass most strongly associated with the pathogenesis of SLE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead402","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T15:43:41Z","timestamp":1691855021000},"page":"1411-1421","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-0055","authenticated-orcid":false,"given":"Yoshikatsu","family":"Kaneko","sequence":"first","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-7163","authenticated-orcid":false,"given":"Hiroe","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"},{"name":"Health Administration Center, Niigata University , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Wakamatsu","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaho","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakatsue","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Health Administration Center, Niigata University , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences , Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,8,12]]},"reference":[{"key":"2024050221002951100_kead402-B1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.1780080205","article-title":"Antibody to ribosomes in systemic lupus erythematosus","volume":"8","author":"Sturgill","year":"1965","journal-title":"Arthritis Rheum"},{"key":"2024050221002951100_kead402-B2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.162.2.459","article-title":"Lupus autoantibodies target ribosomal P proteins","volume":"162","author":"Elkon","year":"1985","journal-title":"J Exp Med"},{"key":"2024050221002951100_kead402-B3","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1073\/pnas.83.19.7419","article-title":"Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus","volume":"83","author":"Elkon","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024050221002951100_kead402-B4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3109\/14397595.2014.884529","article-title":"Efficacy of anti-ribosomal P protein antibody testing for diagnosis of systemic lupus erythematosus","volume":"24","author":"Hirohata","year":"2014","journal-title":"Mod Rheumatol"},{"key":"2024050221002951100_kead402-B5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1741-7015-11-98","article-title":"Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile","volume":"11","author":"Carmona-Fernandes","year":"2013","journal-title":"BMC Med"},{"key":"2024050221002951100_kead402-B6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0961203314560003","article-title":"The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"24","author":"Shi","year":"2015","journal-title":"Lupus"},{"key":"2024050221002951100_kead402-B7","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2024050221002951100_kead402-B8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis","volume":"54","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024050221002951100_kead402-B9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/art.20869","article-title":"Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes","volume":"52","author":"Nagai","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2024050221002951100_kead402-B10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1177\/0961203314546020","article-title":"Anti-ribosomal P antibodies are associated with elevated circulating IFN\u03b1 and IL-10 levels in systemic lupus erythematosus patients","volume":"23","author":"Mozo","year":"2014","journal-title":"Lupus"},{"key":"2024050221002951100_kead402-B11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.2000260","article-title":"Mood disorder in systemic lupus erythematosus induced by antiribosomal P protein antibodies associated with decreased serum and brain tryptophan","volume":"206","author":"Cho","year":"2021","journal-title":"J Immunol"},{"key":"2024050221002951100_kead402-B12","doi-asserted-by":"crossref","first-page":"e000254","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue","volume":"5","author":"\u00c5kesson","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2024050221002951100_kead402-B13","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1111\/febs.16086","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme","volume":"289","author":"Pallotta","year":"2022","journal-title":"FEBS J"},{"key":"2024050221002951100_kead402-B14","doi-asserted-by":"crossref","first-page":"e000808","DOI":"10.1136\/lupus-2022-000808","article-title":"Associations between circulating interferon and kynurenine\/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE","volume":"9","author":"Anderson","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2024050221002951100_kead402-B15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"2024050221002951100_kead402-B16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2024050221002951100_kead402-B17","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2024050221002951100_kead402-B18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jcla.20026","article-title":"Technical and clinical evaluation of anti-ribosomal P protein immunoassays","volume":"18","author":"Mahler","year":"2004","journal-title":"J Clin Lab Anal"},{"key":"2024050221002951100_kead402-B19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","article-title":"Effect of immune activation on the kynurenine pathway and depression symptoms \u2013 a systematic review and meta-analysis","volume":"118","author":"Hunt","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"2024050221002951100_kead402-B20","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/rheumatology\/keac528","article-title":"SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis","volume":"62","author":"Itotagawa","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2024050221002951100_kead402-B21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024050221002951100_kead402-B22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"New Engl J Med"},{"key":"2024050221002951100_kead402-B23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J Exp Med"},{"key":"2024050221002951100_kead402-B24","doi-asserted-by":"crossref","first-page":"970906","DOI":"10.3389\/fimmu.2022.970906","article-title":"IL-10 revisited in systemic lupus erythematosus","volume":"13","author":"Biswas","year":"2022","journal-title":"Front Immunol"},{"key":"2024050221002951100_kead402-B25","first-page":"283","article-title":"Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus","volume":"16","author":"Park","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2024050221002951100_kead402-B26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jaut.1999.0291","article-title":"Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins","volume":"13","author":"Fabien","year":"1999","journal-title":"J Autoimmun"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead402\/51261754\/kead402.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/5\/1411\/57391357\/kead402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/5\/1411\/57391357\/kead402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T21:02:57Z","timestamp":1714683777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/5\/1411\/7241706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,8,12]]},"published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead402","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2023,8,12]]}}}